VLDL is the A1C of the liver

    Most lipid panels report a number that almost no one reads correctly. Read it the way you read A1C, and the rest of the lab panel — and the rest of the body — begins to make sense.

    Read the seriesShop LIV
    For Practitioners

    One signal. Many organs.

    When the liver’s lipid export rises, the signal reaches further than the lipid panel suggests.

    The kidney feels it. Lipid environment injures the cells that build the filter.

    The brain feels it. The barrier that protects it is compromised by what circulates past it.

    The artery feels it. The pattern cardiology has been chasing is downstream of the same hepatic state.

    The pancreas feels it, and sends the signal back. The cascade closes into a loop.

    Five organs. One cascade. The liver at the center.

    Read the full series →

    What LIV was built to do.

    • Supports healthy lipid metabolism

      Helps the liver do its job processing cholesterol and triglycerides, the work that shows up on your next lab report.

    • Improves metabolic efficiency

      Targets how the body produces, uses, and clears energy at the system level, not just one organ in isolation.

    • Cognitive and energy resilience.

      When the liver is properly equipped to do its export work, the systemic effects show up where patients feel them — focus, steadier energy, reduction in brain fog.

    Better lipid panels start with a better-functioning liver.

    LIV Formula No. 1 is a clinically developed supplement that supports the liver’s role in regulating cholesterol, triglycerides, and metabolic function, so your numbers reflect a system that’s actually working.

    Shop LIVThe Science

    Built in clinical practice. Proven in real patients.

    Designed as a system, not a symptom fix

    LIV was formulated to support the liver-centered metabolic processes that govern cholesterol, triglycerides, and energy, not to chase isolated symptoms one at a time.

    Developed in a clinical setting

    LIV wasn’t built for shelf appeal. It was developed inside an active clinical practice, refined based on what worked for actual patients with actual lab results.

    Validated by patient outcomes, not marketing

    Independent pharmacies continue to reorder LIV because their patients keep coming back. Adoption has been driven by what practitioners observe over time.

    Practitioners

    For independent pharmacies looking for a product that patients continue to come back for.

    LIV has been adopted in real-world pharmacy settings based on what practitioners observe over time, not marketing.

    Request Wholesale Access

    The data, in real patients.

    In a real-world cohort of 18 individuals using LIV Formula No. 1, the pattern was consistent and centered on triglyceride metabolism.

    Triglycerides: 217 → 131 mg/dL

    -40%

    VLDL Cholesterol: 43 → 23 mg/dL

    -47%

    Non-HDL Cholesterol: 188 → 145 mg/dL

    -23%

    A shift toward a less atherogenic lipid profile, driven by improvements in triglyceride metabolism, not isolated cholesterol changes.

    This is what the framework predicts: when the liver is supported, the upstream signal moves, and the downstream numbers follow.

    See the full clinical data →

    Who LIV is for

    • People watching their lipid numbers

      Anyone tracking cholesterol, triglycerides, or non-HDL and looking for support beyond diet alone.

    • Adults on multiple medications

      Especially those mindful of how their liver is processing a daily medication load.

    • Anyone told their numbers are “borderline”

      The in-between zone where statins haven’t been prescribed but lab results are trending the wrong way.

    • Health-conscious adults over 40

      When metabolic efficiency starts to shift, supporting the system early is easier than reversing it later.

    Support the system. Watch your numbers.

    VLDL is the A1C of the liver. Developed in clinical practice. Used by real patients. Backed by real data.

    Shop LIVFor Practitioners